Brief: Knight Therapeutics Inc: Entered In Definitive Asset Purchase Agreement With Endo & Paladin Pharma To Acquire Paladin Business

Knight Therapeutics

11/03/2025 10:48

March 11 (Reuters) - Paladin Ltd 0495.HK:

KNIGHT THERAPEUTICS INC: WILL PAY AN UPFRONT PAYMENT OF $120 MILLION IN CASH, INCLUDING INVENTORY WITH A VALUE OF $20 MILLION

KNIGHT THERAPEUTICS INC: ENTERED IN DEFINITIVE ASSET PURCHASE AGREEMENT WITH ENDO & PALADIN PHARMA  TO ACQUIRE PALADIN BUSINESS

KNIGHT THERAPEUTICS INC: MAY PAY FUTURE CONTINGENT PAYMENTS OF UP TO $15 MILLION UPON ACHIEVING CERTAIN SALES MILESTONES

Source text: ID:nGNX7nXztv

Further company coverage: 0495.HK

 ((Reuters.Briefs@thomsonreuters.com;))